The risks of digital health companies to psychiatric patients
In early 2022, during the coronavirus pandemic, I considered practicing psychiatry via telehealth. I looked into two telemental-health companies in particular—Cerebral and Done Global, Inc. (hereafter “Done”)—and turned them both down. I did not believe their ethics measured up. In the case of Done, I asked to be withdrawn from consideration as medical director because I believed the company lacked adequate infrastructure and was exclusively focused on treating patients with …
